Company registration number 15313203 (England and Wales)
THE FAMILY CHEMIST LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2025
PAGES FOR FILING WITH REGISTRAR
THE FAMILY CHEMIST LTD
CONTENTS
Page
Statement of financial position
1 - 2
Notes to the financial statements
3 - 9
THE FAMILY CHEMIST LTD
STATEMENT OF FINANCIAL POSITION
AS AT 30 NOVEMBER 2025
30 November 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
4
129,575
13,083
Current assets
Stocks
5
449,626
175,896
Debtors
6
1,078,681
692,898
Cash at bank and in hand
3,039,409
4,138,744
4,567,716
5,007,538
Creditors: amounts falling due within one year
7
(4,075,713)
(3,378,802)
Net current assets
492,003
1,628,736
Total assets less current liabilities
621,578
1,641,819
Creditors: amounts falling due after more than one year
8
-
0
(1,619,156)
Provisions for liabilities
9
(23,000)
-
Net assets
598,578
22,663
Capital and reserves
Called up share capital
10
600
600
Profit and loss reserves
597,978
22,063
Total equity
598,578
22,663
THE FAMILY CHEMIST LTD
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 30 NOVEMBER 2025
30 November 2025
- 2 -

For the financial year ended 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the income statement within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 28 April 2026 and are signed on its behalf by:
Mr S Dhain
Director
Company registration number 15313203 (England and Wales)
THE FAMILY CHEMIST LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 3 -
1
Accounting policies
Company information

The Family Chemist Ltd is a private company limited by shares incorporated in England and Wales. The registered office is Unit1 Nottingham South & Wilford Industrial Estate, Nottingham, NG11 7EP.

1.1
Reporting period

These financial statements are for the year ended 30 November 2025. They represent the second year of operations for the company, following the incorporation on 28 November 2023. Therefore, the comparative information presented for the period ended 30 November 2024 is not entirely comparable.

1.2
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.3
Going concern

A true t the time of approving the financial statements, t he directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus t he directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.4
Revenue

Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.

1.5
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Leasehold improvements
10% straight line
Plant and equipment
25% reducing balance
Fixtures and fittings
15% reducing balance
Computers
15% reducing balance
Motor vehicles
20% reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

THE FAMILY CHEMIST LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
1
Accounting policies
(Continued)
- 4 -
1.6
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

1.7
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.8
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.9
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

THE FAMILY CHEMIST LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
1
Accounting policies
(Continued)
- 5 -
Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.10
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.11
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the income statement, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.12
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

THE FAMILY CHEMIST LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
1
Accounting policies
(Continued)
- 6 -
1.13
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.14
Leases
As lessee

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the lease s asset are consumed.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
26
10
THE FAMILY CHEMIST LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 7 -
4
Tangible fixed assets
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 1 December 2024
-
0
13,591
13,591
Additions
45,268
85,643
130,911
At 30 November 2025
45,268
99,234
144,502
Depreciation and impairment
At 1 December 2024
-
0
508
508
Depreciation charged in the year
1,636
12,783
14,419
At 30 November 2025
1,636
13,291
14,927
Carrying amount
At 30 November 2025
43,632
85,943
129,575
At 30 November 2024
-
0
13,083
13,083
5
Stocks
2025
2024
£
£
Stocks
449,626
175,896
6
Debtors
2025
2024
Amounts falling due within one year:
£
£
Other debtors
1,078,681
692,898
7
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
2,789,126
2,573,166
Taxation and social security
1,174,489
658,153
Other creditors
112,098
147,483
4,075,713
3,378,802
THE FAMILY CHEMIST LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 8 -
8
Creditors: amounts falling due after more than one year
2025
2024
£
£
Other creditors
-
0
1,619,156
9
Provisions for liabilities
2025
2024
£
£
Deferred tax liabilities
23,000
-
0
10
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
200
200
200
200
A Ordinary shares of £1 each
200
200
200
200
B Ordinary shares of £1 each
200
200
200
200
600
600
600
600

The rights attached to each category of share can be found in the company's Articles of Association.

11
Operating lease commitments
As lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2025
2024
£
£
Total commitments
310,231
133,154
12
Related party transactions

The company has related parties by virtue of common shareholding and directorship.

At 30 November 2025, included within other creditors falling due within one year are amounts totalling £Nil (2024: £119,864) due to related parties.

At 30 November 2025, included within other creditors falling due after more than one year are amounts totalling £Nil (2024: £1,616,000) due to related parties.

13
Directors' transactions

At 30 November 2025, included within other debtors are loans totalling £600,000 (2024: £Nil) to the company's directors'. These have been fully repaid within 9 months of the year end and interest has been charged at the commercial rate.

THE FAMILY CHEMIST LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 9 -
14
Parent company

The company is a 100% subsidiary of Dhain Investments Li mited, a company registered in England and Wales.

2025-11-30 2024-12-01 false false false 28 April 2026 CCH Software CCH Accounts Production 2026.100 No description of principal activity Mrs N Dhain Mr S Dhain 15313203 2024-12-01 2025-11-30 15313203 2025-11-30 15313203 2024-11-30 15313203 core:LandBuildings 2025-11-30 15313203 core:OtherPropertyPlantEquipment 2025-11-30 15313203 core:LandBuildings 2024-11-30 15313203 core:OtherPropertyPlantEquipment 2024-11-30 15313203 core:CurrentInventories 2025-11-30 15313203 core:CurrentInventories 2024-11-30 15313203 core:CurrentFinancialInstruments core:WithinOneYear 2025-11-30 15313203 core:CurrentFinancialInstruments core:WithinOneYear 2024-11-30 15313203 core:Non-currentFinancialInstruments core:AfterOneYear 2025-11-30 15313203 core:Non-currentFinancialInstruments core:AfterOneYear 2024-11-30 15313203 core:CurrentFinancialInstruments 2025-11-30 15313203 core:CurrentFinancialInstruments 2024-11-30 15313203 core:ShareCapital 2025-11-30 15313203 core:ShareCapital 2024-11-30 15313203 core:RetainedEarningsAccumulatedLosses 2025-11-30 15313203 core:RetainedEarningsAccumulatedLosses 2024-11-30 15313203 core:ShareCapitalOrdinaryShareClass1 2025-11-30 15313203 core:ShareCapitalOrdinaryShareClass1 2024-11-30 15313203 core:ShareCapitalOrdinaryShareClass2 2025-11-30 15313203 core:ShareCapitalOrdinaryShareClass2 2024-11-30 15313203 core:ShareCapitalOrdinaryShareClass3 2025-11-30 15313203 core:ShareCapitalOrdinaryShareClass3 2024-11-30 15313203 core:ShareCapitalOrdinaryShares 2025-11-30 15313203 core:ShareCapitalOrdinaryShares 2024-11-30 15313203 bus:Director2 2024-12-01 2025-11-30 15313203 core:LeaseholdImprovements 2024-12-01 2025-11-30 15313203 core:PlantMachinery 2024-12-01 2025-11-30 15313203 core:FurnitureFittings 2024-12-01 2025-11-30 15313203 core:ComputerEquipment 2024-12-01 2025-11-30 15313203 core:MotorVehicles 2024-12-01 2025-11-30 15313203 2023-11-28 2024-11-30 15313203 core:LandBuildings 2024-11-30 15313203 core:OtherPropertyPlantEquipment 2024-11-30 15313203 2024-11-30 15313203 core:LandBuildings 2024-12-01 2025-11-30 15313203 core:OtherPropertyPlantEquipment 2024-12-01 2025-11-30 15313203 core:Non-currentFinancialInstruments 2025-11-30 15313203 core:Non-currentFinancialInstruments 2024-11-30 15313203 bus:OrdinaryShareClass1 2024-12-01 2025-11-30 15313203 bus:OrdinaryShareClass2 2024-12-01 2025-11-30 15313203 bus:OrdinaryShareClass3 2024-12-01 2025-11-30 15313203 bus:OrdinaryShareClass1 2025-11-30 15313203 bus:OrdinaryShareClass1 2024-11-30 15313203 bus:OrdinaryShareClass2 2025-11-30 15313203 bus:OrdinaryShareClass2 2024-11-30 15313203 bus:OrdinaryShareClass3 2025-11-30 15313203 bus:OrdinaryShareClass3 2024-11-30 15313203 bus:AllOrdinaryShares 2025-11-30 15313203 bus:AllOrdinaryShares 2024-11-30 15313203 bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 15313203 bus:SmallCompaniesRegimeForAccounts 2024-12-01 2025-11-30 15313203 bus:FRS102 2024-12-01 2025-11-30 15313203 bus:AuditExemptWithAccountantsReport 2024-12-01 2025-11-30 15313203 bus:Director1 2024-12-01 2025-11-30 15313203 bus:FullAccounts 2024-12-01 2025-11-30 xbrli:pure xbrli:shares iso4217:GBP